Initially built in 1948 and experienced 70-years’ changes, Shijiazhuang No.4 Pharmaceutical Co., Ltd has developed into a large-scale pharmaceutical enterprise.

 

SEVENTY YEARS OF HISTORY

Every year about 20 new products are put into market, 70% of sales come from the new products and high-tech products.

 

MULTIPLE RESEARCH RESULTS

QUALITY ASSURANCE

As a pharmaceutical company, product quality not only relates to patients’ life, but also concerns the development of enterprise.

The company mainly manufactures large and small volume injection, capsule, granule, tablet, dried suspension, washing fluid, and oral liquid with more than 100 kinds.

 

OUR PRODUCTS

MAKE HIGH QUALITY MEDICINE FOR HUMAN BEING

New Product

Every year More than 10      new products are put    into market. In 2018, Moxifloxacin Injection, Sodium Acetate Ringer's Injection and Hemofiltration Replaced Basic Fluid have been approved by SFDA.

Large Volume Injection

The yearly ouput of key product large volume I.V solutionhas reached more than 1.5 billion bottles with glass bottle, plastic bottle and bag.

Small Volume Injection

The production line uses BFS three-in-one technology of Switzerland Rommelag Company.

Oral Preparation

Capsules, tablets, granules,     oral liquids and other                 dosage forms are manufactured for patients.

Raw Material API

The main products are caffeine, theophylline, aminophylline and other products.

Each year we attend more than 10 world-wide exhibition to meet with customers from different countries and more than 30 foreign traders visit our company.

LATEST NEWS

Merck Announces Acquisition of Sigma-Aldrich for $14 Billion
Merck Announces Acquisition of Sigma-Aldrich for $14 Billion
Abstract:
Merck & Co., Germany, announced on Monday that it will acquire Sigma Aldrich Life Sciences for a total of $14 billion per share for a total of $14 billion
2018-07-22 16:47
Retrospective development of anticancer drugs
Retrospective development of anticancer drugs
Abstract:
Traditional anti-tumor drugs act on DNA replication and cell differentiation, and although they have serious side effects, they are still very effective in treating some cancers.
2018-07-22 16:44
National Strategy: China's precision medicine is making big strides forward
National Strategy: China's precision medicine is making big strides forward
Abstract:
At present, the precision medical industry cluster represented by the United States and China and Europe is taking shape.
2018-07-22 16:41

OUR FACTORY

 

Shijiazhuang No.4 Pharmaceutical Co., Ltd achieved full automation of the production process and logistics management, and created a low-cost, low energy consumption and environmentally friendly leading and advanced infusion industry "green" production demonstration park in China and the world.

Full-controlled and full-closed...

The full-controlled batching system adopts the inter- national leading technical design of totally-enclosure system and realizes automatic cleaning, batching, weighing, on-line sterlization and automatic detection.

Full-controlled Water System

The full-controlled water system adopts advanced two-stage reverse osmosis membrane filtration technology and multi-effect energy-saving distillation technology, realizes automatic on-line detection, record, control and automatic flow regulation.

Products R&D Center

The comprehensive R&D center with total building area of 13000 ㎡ and its Support Animals Experiment Center of 2500 ㎡ are composed of Chinese and Western Medicines Laboratory, Quality Laboratory, Open Research Center and Intercourse Center.

Contact Us

Contact us!

Add: No. 288,Zhujiang Road, High-tech Industrial

Development,Shijiazhuang, Hebei, China
Web: www.sjzsiyao.com  www.ssypc.com
Tel: 86 311 67167137 67167144
E-mail:
trade@sjzsiyao.com / chinainfusion@163.com
Skype: xlmamary

Web Copyright: Shijiazhuang No.4 Pharmaceutical Co., Ltd.    Powered by www.300.cn   冀ICP备05007979号

About Us

Online Message